Previous 10 | Next 10 |
Selected for Oral Presentation Study done in the CMT1A mouse model Supported by the CMT Research Foundation MADRID, Spain and BOSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leverag...
MADRID, Spain and BOSTON, May 17, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today announced the presentation of the trial in prog...
2023-05-16 15:44:17 ET Summary Orion Group finally has a $36 million signed P&S for its East West Jones Property in Houston. They will receive most of the after tax proceeds, after transaction fees. The company has a $1.1 billion backlog, its highest in ages. The company i...
HOUSTON, May 16, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the "Company"), a leading specialty construction company, today announced the closing of a new 3-year $103 million senior secured asset based credit facility with White Oak ABL, LLC and White Oak Commercial Finance,...
Positive results from interim analysis of vafidemstat's PORTICO Phase IIb trial in Borderline Personality Disorder Recruiting patients in FRIDA trial with iadademstat in combination with gilteritinib in relapsed/refractory FLT3-mutant AML patients ORY-4001, a selective HDAC-6 inhi...
2023-05-09 15:17:08 ET Orion Group Holdings, Inc. (ORN) Q1 2023 Earnings Conference Call May 09, 2023 09:00 AM ET Company Participants Margaret Boyce - Investor Relations Travis Boone - Chief Executive Officer Scott Thanisch - Chief Financial Officer Confer...
BioEquity Europe 2023 Foro Medcap BME 2023 VI Ibero-American Congress CEAPI 2023 BIO International Conference 2023 Jefferies Healthcare Conference 2023 MidCap Paris 2023 MADRID and BOSTON, May 09, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (...
2023-05-08 18:07:33 ET Orion Group press release ( NYSE: ORN ): Q1 GAAP EPS of -$0.39. Revenue of $159.2M (-9.0% Y/Y). Total backlog at March 31, 2023 was $467.4 million, compared to $448.8 million at December 31, 2022 and $604.1 million at March 31, 2022. ...
HOUSTON, May 08, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today reported its financial results for the first quarter ended March 31, 2023. Highlights for the quarter ended March 31, 2023: ...
HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the "Company"), a leading specialty construction company, today announced that it will issue its financial results for the first quarter ended March 31, 2023 on Monday, May 8, 2023, after the close of the stock ma...
News, Short Squeeze, Breakout and More Instantly...
Orion Group Holdings Inc. Common Company Name:
ORN Stock Symbol:
NYSE Market:
Orion Group Holdings Inc. Common Website:
MADRID and CAMBRIDGE, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that it has received “Deci...
HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (“Orion”, "Company"), a leading specialty construction company, today announced that it will issue its second quarter 2024 financial results after the close of the stock market on Wednesday, July 24, 2...
2024-07-06 15:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...